Cycle-length evidence
SNAP-8 cycle length: what human studies ran
Not approved — research use only
Short answer: there is no established SNAP-8 cycle length, and we found no human studies that report one.
Treatment and follow-up in human studies
No human study durations are recorded.
What has not been tested
- On-and-off schedules or breaks between courses.
- Repeated courses and long-term exposure beyond the periods listed.
- SNAP-8 combined with other compounds, unless a study above says so.
Frequently asked questions
Is there an established SNAP-8 cycle length?
No. We found no human studies that report a treatment duration for SNAP-8.
What is the longest human study of SNAP-8?
None is recorded.
Do study durations tell me how long to use something?
No. A study duration is how long investigators administered a compound to selected participants under monitoring. It is not a recommended course, and a break between courses has not been tested for any compound on this site that is not approved.
References
- Acetyl octapeptide-3 (CID 76283482): compound summary, synonyms and computed properties PubChem. 2026
- Efficacy of bioactive peptides loaded on hyaluronic acid microneedle patches: A monocentric clinical study Journal of Cosmetic Dermatology. 2020
- Clinical Safety and Efficacy Evaluation of a Dissolving Microneedle Patch Having Dual Anti-Wrinkle Effects With Safe and Long-Term Activities Annals of Dermatology. 2024
- Skin scars and wrinkles temporary camouflage in dermatology and oncoesthetics: focus on acetyl hexapeptide-8 Clinica Terapeutica. 2020
- Polydioxanone Bioactive Sutures-Acetyl Hexapeptide-8 (Argireline): An Intelligent System for Controlled Release in Facial Harmonization Journal of Cutaneous and Aesthetic Surgery. 2023
- Bulk Drug Substances Nominated for Use in Compounding Under Section 503A of the Federal Food, Drug, and Cosmetic Act (updated May 14, 2026) FDA. 2026
- PubMed search for acetyl octapeptide-3 (two records, both multi-ingredient microneedle patch studies) PubMed. 2026
- Public Interest in Acetyl Hexapeptide-8: Longitudinal Analysis JMIR Dermatology. 2024
- World Anti-Doping Code International Standard Prohibited List 2026 WADA. 2026